EARLY FEASIBILITY STUDIES | STRUCTURAL

Monday, March 10, 2025

11:45 AM – 12:45 PM ET

Moderator(s)

Toby Rogers, MD, PhD

Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease
Georgetown University and MedStar Washington Hospital Center
Washington, District of Columbia, United States

Disclosure(s): Abbott: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Transmural Systems, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing)

Panelist(s)

Amr Abbas, MD

Director, Structural Heart and Cardiovascular Research
Corewell Health, Michigan, United States

Disclosure(s): Anteris: Consultant (Ongoing); Edward’s life sciences: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Karim Al-Azizi, MD, FACC, FSCAI, FESC

Medical Director, Cardiac Catheterization Laboratories
The Heart Hospital, Baylor Scott & White Health Baylor Scott & White
Frisco, Texas, United States

Disclosure(s): Abbott Labs: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); shockwave: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Mayra E. Guerrero, MD, FACC, FSCAI

Professor of Medicine
Mayo Clinic Hospital
Rochester, Minnesota, United States

Disclosure information not submitted.
Steven F. Bolling, MD

Professor of Cardiac Surgery
University of Michigan Hospital
Ann Arbor, Michigan, United States

Disclosure(s): Tangent: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); xDOT: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Jason H. Rogers, MD

Professor, Cardiovascular Medicine
University of California, Davis Medical Center
Sacramento, California, United States

Disclosure(s): Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); BioSense Webster, a J&J Company: Consultant (Ongoing)

Disclosure(s):

Toby Rogers, MD, PhD: Abbott: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Transmural Systems, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing)

Amr Abbas, MD: Anteris: Consultant (Ongoing); Edward’s life sciences: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Karim Al-Azizi, MD, FACC, FSCAI, FESC: Abbott Labs: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); shockwave: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Steven F. Bolling, MD: Tangent: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); xDOT: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Jason H. Rogers, MD: Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); BioSense Webster, a J&J Company: Consultant (Ongoing)